Moderna (NASDAQ: MRNA) gained recognition for its role in developing a COVID-19 vaccine using innovative messenger RNA (mRNA) technology, which allows for rapid drug development. However, potential investors should carefully consider the company’s future prospects beyond its pandemic success before deciding to buy its stock.
